Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab.

Radiol Oncol · 2025 · PMC12707446 · PMID 41401058

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

borderline significantp = 0.053so close (0.05 < p ≤ 0.1)

The association between multiorgan metastases and PFS remained borderline significant (HR: 3.80; 95% CI: 0.98–14.80; p = 0.053) ( Table 4 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.